Kane, J, Honigfeld, G, Singer, J, Meltzer, H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry
1988; 45: 789–96.
Howes, OD, Vergunst, F, Gee, S, McGuire, P, Kapur, S, Taylor, D. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation. Br J Psychiatry
2012; 201: 481–5.
National Institute for Health and Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Update)
. NICE, 2009.
Taylor, DM, Young, C, Paton, C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. J Clin Psychiatry
2003; 64: 30–4.
Nielson, J, Dahm, M, Lublin, H, Taylor, D. Psychiatrists' attitude towards and knowledge of clozapine treatment. J Psychopharmacol
2010; 24: 965–71.
Farooq, S, Taylor, M. Clozapine: dangerous orphan or neglected friend?
Br J Psychiatry
2011; 198: 247–9.
Taylor, DM, Douglas-Hall, P, Olofinjana, B, Whiskey, E, Thomas, A. Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection. Br J Psychiatry
2009; 194: 165–7.
Tiihonen, J, Lonnqvist, J, Wahlbeck, K, Klaukka, T, Niskanen, L, Tanskanen, A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet
2009; 374: 620–7.
Whiskey, E, Olofinjana, O, Taylor, D. The importance of the recognition of benign ethnic neutropenia in black patients during treatment with clozapine: case reports and database study. J Psychopharmacol
2011; 25: 842–5.
Pai, NB, Vella, SC. Reason for clozapine cessation. Acta Psychiatr Scand
2011; 124: 39–44.
Taylor, D, Paton, C, Kapur, S. Maudsley Prescribing Guidelines, 11th Edition.
Wiley Blackwell, 2012.
Leucht, S, Corves, C, Arbter, D, Engel, RR, Li, C, Davis, JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a metaanalysis. Lancet
2009; 373: 31–41.
Girgis, RR, Phillips, MR, Li, X, Li, K, Jiang, H, Wu, C, et al. Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial. Br J Psychiatry
2011; 199: 281–8.
Lewis, SW, Barnes, TR, Davies, L, Murray, RM, Dunn, G, Hayhurst, KP, et al. Randomized controlled trial of effect of prescription for clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull
2006; 32: 715–23.
McEvoy, JP, Liebermann, JA, Stroup, TS, Davis, SM, Meltzer, HY, Rosenheck, RA, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry
2006; 163: 600–10.
Couchman, L, Morgan, PE, Spencer, EP, Flanagan, RJ. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service. Ther Drug Monit
2010; 32: 438–47.
Couchman, L, Bowskill, SV, Handley, S, Patel, MX, Flanagan, RJ. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged < 18 years: data from a therapeutic drug monitoring service, 1994-2010. Early Interv Psychiatry
Tiihonen, J, Haukka, J, Taylor, M, Haddad, PM, Patel, MX, Korhonen, P. A nationwide cohort study of oral and depot antipsychotics after first hopitalization for schizophrenia. Am J Psychiatry
2011; 168: 603–9.
Downs, J, Zinkler, M. Clozapine: national review of postcode prescribing. Psychiatr Bull
2007; 31: 384–7.
Patel, MX, David, AS. Why aren't depot antipsychotics prescribed more often and what can be done about it?
Adv Psychiatr Treat
2005; 11: 203–11.
Best-Shaw, L, Nagar, J, David, AS, Rose, D, Patel, MX. Psychiatrists' perspectives regarding antipsychotics: Dose choice and plasma level therapeutic drug monitoring. J Psychopharmacol
2012; 26 (suppl 8): A39.
Harrison, PJ, Baldwin, DS, Barnes, TRE, Burns, T, Ebmeier, KP, Ferrier, IN, et al. No psychiatry without psychopharmacology. Br J Psychiatry
2011; 199: 263–5.